Antibody Engineering & Therapeutics Asia

| Tokyo, Japan
Retrogenix exhibition banner

“World-renowned scientists sharing the latest technologies, R&D and clinical data to fast-track next-generation therapeutics towards commercial success.”

Mark Aspinall-O’Dea will be presenting strategies for uncovering critical receptor targets and assessing the specificity of biotherapeutics, using case studies from industry partners and academic collaborators. We will also be exhibiting at the meeting.

For further details, please see the conference website.

Back to News